EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Estrogen, inflammation, and platelet phenotype

Virginia M Miller, Muthuvel Jayachandran, Kazumori Hashimoto, John A Heit, Whyte G Owen

Gender Medicine · 2008

DOI: 10.1016/j.genm.2008.03.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Gender Medicine, 2008. Verfasst von Virginia M Miller und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. miller.virginia@mayo.edu. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although exogenous estrogenic therapies increase the risk of thrombosis, the effects of estrogen on formed elements of blood are uncertain. OBJECTIVE: This article examines the genomic and nongenomic actions of estrogen on platelet phenotype that may contribute to increased thrombotic risk. METHODS: To determine aggregation, secretion, protein expression, and thrombin generation, platelets were collected from experimental animals of varying hormonal status and from women enrolled in the Kronos Early Estrogen Prevention Study. RESULTS: Estrogen receptor beta predominates in circulating platelets. Estrogenic treatment in ovariectomized animals decreased platelet aggregation and adenosine triphosphate (ATP) secretion. However, acute exposure to 17beta-estradiol did not reverse decreases in platelet ATP secretion invoked by lipopolysaccharide. Thrombin generation was positively correlated to the number of circulating microvesicles expressing phosphatidylserine. CONCLUSION: Assessing the effect of estrogen treatments on blood platelets may lead to new ways of identifying women at risk for adverse thrombotic events with such therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsBlood PlateletsEstradiolEstrogen Receptor betaEstrogensGenetic Predisposition to DiseaseHumansLipopolysaccharidesMenopausePlatelet AggregationReceptors, EstrogenThrombosisToll-Like Receptor 4

Substanzen

Estrogen Receptor betaEstrogensLipopolysaccharidesReceptors, EstrogenTlr4 protein, mouseToll-Like Receptor 4Estradiol

Autor:innen und Institutionen

  • Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. miller.virginia@mayo.edu

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Miller, V. M., Jayachandran, M., Hashimoto, K., Heit, J. A., & Owen, W. G. (2008). Estrogen, inflammation, and platelet phenotype. Gender Medicine. https://doi.org/10.1016/j.genm.2008.03.009

Vancouver

Miller VM, Jayachandran M, Hashimoto K, Heit JA, Owen WG. Estrogen, inflammation, and platelet phenotype. Gender Medicine. 2008. doi:10.1016/j.genm.2008.03.009

BibTeX
@article{Miller2008,
  author = {Miller, Virginia M and Jayachandran, Muthuvel and Hashimoto, Kazumori and Heit, John A and Owen, Whyte G},
  title = {Estrogen, inflammation, and platelet phenotype},
  journal = {Gender Medicine},
  year = {2008},
  doi = {10.1016/j.genm.2008.03.009}
}
Kostenlos starten →